Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Stocks of Local Interest
PG Energy Index
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Aprea Therapeutics Inc
(NQ:
APRE
)
5.150
-0.060 (-1.15%)
Official Closing Price
Updated: 7:59 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Aprea Therapeutics Inc
< Previous
1
2
3
4
Next >
45 Stocks Moving in Wednesday's Pre-Market Session
January 13, 2021
Gainers Summit Midstream Partners, LP (NYSE: SMLP) shares rose 58.3% to $21.67 in pre-market trading after the company reported ...
Tags
JAGX
TNXP
Movers
From
Benzinga
Aprea Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021
January 08, 2021
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data
January 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ENDP
FDMT
BNGO
From
Benzinga
Stocks That Hit 52-Week Lows On Monday
January 04, 2021
During Monday's morning session, 9 stocks hit new 52-week lows. Points of Interest: The largest company in terms ...
Tags
Trading Ideas
WRAP
CHL
From
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
December 30, 2020
Wednesday's morning session saw 5 companies set new 52-week lows. Areas of Significance: Vital Farms (NASDAQ: ...
Tags
Market News
APRE
Benzinga
From
Benzinga
The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data
December 30, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
IBB
ABCL
AVIR
From
Benzinga
Benzinga's Top Upgrades, Downgrades For December 29, 2020
December 29, 2020
Upgrades For Continental Resources Inc (NYSE:CLR), KeyBanc upgraded the previous rating of Sector Weight to Overweight. ...
Tags
BYSI
Intraday Update
SGTX
From
Benzinga
7 Biggest Price Target Changes For Tuesday
December 29, 2020
HC Wainwright & Co. lowered the price target for Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) from $84 to $50. Arcturus ...
Tags
Small Cap
LNTH
SNAP
From
Benzinga
The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
December 29, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ALKS
NARI
VCEL
From
Benzinga
Sum Up The Parts: IBB Could Be Worth $181
December 29, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
84 Biggest Movers From Yesterday
December 29, 2020
Gainers AeroCentury Corp. (NYSE: ACY) shares climbed 414.9% to close at $13.85 on Monday after the company reported that the NYSE ...
Tags
RIOT
YELP
GHSI
From
Benzinga
Mid-Afternoon Market Update: Nasdaq Jumps Over 100 Points; AeroCentury Shares Spike Higher
December 28, 2020
Toward the end of trading Monday, the Dow traded up 0.67% to 30,403.22 while the NASDAQ rose 0.87% to 12,916.04. The S&P also rose, ...
Tags
AIRT
Markets
ACY
From
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 28, 2020
Gainers Poseida Therapeutics (NASDAQ:PSTX) shares increased by 43.08% to $13.25 during Monday's regular session. As ...
Tags
Benzinga
Markets
Market News
From
Benzinga
Mid-Day Market Update: Dow Surges 240 Points; Aprea Therapeutics Shares Plunge
December 28, 2020
Midway through trading Monday, the Dow traded up 0.79% to 30,441 while the NASDAQ rose 0.69% to 12,893.08. The S&P also rose, ...
Tags
News
Benzinga
Markets
From
Benzinga
Aprea Therapeutics Enters Oversold Territory (APRE)
December 28, 2020
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Tags
Stocks
From
Market News Video
58 Stocks Moving In Monday's Mid-Day Session
December 28, 2020
Gainers AeroCentury Corp. (NYSE: ACY) shares jumped 227.2% to $8.80 after the company reported that the NYSE accepted its plan for ...
Tags
SRAX
SENS
AIRT
From
Benzinga
Mid-Morning Market Update: Markets Open Higher; President Trump Signs $900B Covid-19 Relief Bill
December 28, 2020
Following the market opening Monday, the Dow traded up 0.91% to 30,473.61 while the NASDAQ rose 0.25% to 12,837.34. The S&P also ...
Tags
Global
Mid/Morning Market Update
GEVO
From
Benzinga
Stocks That Hit 52-Week Lows On Monday
December 28, 2020
During the morning session on Monday, 5 stocks hit new 52-week lows. Noteables: The largest company by market cap to ...
Tags
News
ABCL
Market News
From
Benzinga
Aprea Therapeutics Announces Results of Primary Endpoint from Phase 3 Trial of Eprenetapopt in TP53 Mutant Myelodysplastic Syndromes (MDS)
December 28, 2020
From
GlobeNewswire News Releases
The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks
December 26, 2020
Biotech stocks advanced for a fifth straight week in thin holiday trading. The gains, however, were more modest amid worries concerning ...
Tags
SBTX
RDHL
RHHBY
From
Benzinga
Benzinga's Top Upgrades, Downgrades For December 16, 2020
December 16, 2020
Upgrades For Amplify Energy Corp (NYSE: AMPY), Roth Capital upgraded the previous rating of Neutral to the current rating Buy. For ...
Tags
PFE
CMG
HAIN
From
Benzinga
Aprea Therapeutics (APRE) Shares Cross Above 200 DMA
December 07, 2020
In trading on Monday, shares of Aprea Therapeutics Inc (APRE) crossed above their 200 day moving average of $29.56, changing hands as high as $30.70 per share. Aprea Therapeutics Inc shares are...
Tags
Stocks
From
Market News Video
Aprea Therapeutics Receives FDA Fast Track Designation for Eprenetapopt in the Treatment of TP53 Mutant Acute Myeloid Leukemia (AML)
November 30, 2020
From
GlobeNewswire News Releases
3 Stocks with Jaw-Dropping Growth Potential
November 23, 2020
Aprea Therapeutics, Viking Therapeutics, and Vaxart could all generate life-changing returns for early shareholders.
Tags
VXRT
VKTX
APRE
From
Motley Fool
66 Biggest Movers From Friday
November 23, 2020
Gainers Kaixin Auto Holdings (NASDAQ: KXIN) shares jumped 103.3% to close at $6.06 on Friday. FTS International Inc (NYSE: FTSI) ...
Tags
NAKD
DADA
TTNP
From
Benzinga
Aprea Therapeutics to Participate in the 32nd Annual Piper Sandler Healthcare Conference
November 19, 2020
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold
November 06, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
TARS
PRAH
STRO
From
Benzinga
Aprea Therapeutics Reports Third Quarter 2020 Financial Results and Provides Update on Business Operations
November 05, 2020
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings
November 04, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
GTHX
BLRX
SGMO
From
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 03, 2020
During Tuesday's morning trading, 12 companies set new 52-week lows. Things to Consider: The largest company in ...
Tags
Benzinga
Markets
METX
From
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.